Molecular genetic aspects of prostate transition zone lesions.
Pavelić
Jasminka
J
Division of Molecular Medicine, Rudjer Bosković Institute, Zagreb, Croatia.
Zeljko
Zarko
Z
Bosnar
Maja Herak
MH
D000230:Adenocarcinoma / Q000737:chemistry / Q000235:genetics* / Q000473:pathology; D000368:Aged; D000369:Aged, 80 and over; D000782:Aneuploidy; D020869:Gene Expression Profiling; D016147:Genes, Tumor Suppressor; D006133:Growth Substances / Q000235:genetics; D006801:Humans; D008297:Male; D008875:Middle Aged; D020411:Oligonucleotide Array Sequence Analysis; D009857:Oncogenes; D011230:Precancerous Conditions / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D011467:Prostate / Q000737:chemistry* / Q000648:ultrastructure; D011470:Prostatic Hyperplasia / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D019048:Prostatic Intraepithelial Neoplasia / Q000737:chemistry / Q000235:genetics / Q000473:pathology; D011471:Prostatic Neoplasms / Q000737:chemistry / Q000235:genetics* / Q000473:pathology
D006133:Growth Substances